HOXA2
Homeobox protein Hox-A2
Also known as: HOX1K, HXA2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43364
- Gene
- HOXA2
- Ensembl
- ENSG00000105996
- Chromosome
- 7
- Canonical length
- 376 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
In vertebrates, the genes encoding the class of transcription factors called homeobox genes are found in clusters named A, B, C, and D on four separate chromosomes. Expression of these proteins is spatially and temporally regulated during embryonic development. This gene is part of the A cluster on chromosome 7 and encodes a DNA-binding transcription factor which may regulate gene expression, morphogenesis, and differentiation. The encoded protein may be involved in the placement of hindbrain segments in the proper location along the anterior-posterior axis during development. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
376 residues, UniProt reviewed canonical sequence.
>O43364|HOXA2
1 MNYEFEREIG FINSQPSLAE CLTSFPPVAD TFQSSSIKTS TLSHSTLIPP PFEQTIPSLN
61 PGSHPRHGAG GRPKPSPAGS RGSPVPAGAL QPPEYPWMKE KKAAKKTALL PAAAAAATAA
121 ATGPACLSHK ESLEIADGSG GGSRRLRTAY TNTQLLELEK EFHFNKYLCR PRRVEIAALL
181 DLTERQVKVW FQNRRMKHKR QTQCKENQNS EGKCKSLEDS EKVEEDEEEK TLFEQALSVS
241 GALLEREGYT FQQNALSQQQ APNGHNGDSQ SFPVSPLTSN EKNLKHFQHQ SPTVPNCLST
301 MGQNCGAGLN NDSPEALEVP SLQDFSVFST DSCLQLSDAV SPSLPGSLDS PVDISADSLD
361 FFTDTLTTID LQHLNYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HOXA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 6.7 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 6.7 nTPM
- parathyroid gland: 5.3 nTPM
- epididymis: 4.8 nTPM
- blood vessel: 4.2 nTPM
- fallopian tube: 3.8 nTPM
- kidney: 3.5 nTPM
Single-cell type
- epididymal efferent duct absorptive cells: 16 nCPM
- tuft cells: 12 nCPM
- epididymal efferent duct ciliated cells: 5.9 nCPM
- epididymal basal cells: 5 nCPM
- medullary thymic epithelial cells: 4.8 nCPM
- breast myoepithelial cells: 4.3 nCPM
Immune cell
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- spinal cord: 10 nTPM
- medulla oblongata: 9.7 nTPM
- white matter: 8.9 nTPM
- pons: 6.5 nTPM
- midbrain: 0.3 nTPM
- thalamus: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HOXA2.
Disease | AllUniProt
Conditions HOXA2 is implicated in, by any mechanism.
- Microtia, hearing impairment, and cleft palate (MHICP) MIM:612290
- Microtia with or without hearing impairment (MCRT) MIM:612290
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 108 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Bilateral microtia-deafness-cleft palate syndrome
- HOXA2-related disorder
- MICROTIA WITH OR WITHOUT HEARING IMPAIRMENT
- MICROTIA WITHOUT HEARING IMPAIRMENT
- Hearing impairment
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.2
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterior/posterior pattern specification
- brain segmentation
- cell fate determination
- cellular response to retinoic acid
- dorsal/ventral pattern formation
- embryonic viscerocranium morphogenesis
- middle ear morphogenesis
- motor neuron axon guidance
- muscle structure development
- negative regulation of neuron differentiation
- negative regulation of osteoblast differentiation
- osteoblast development
- pharyngeal system development
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
- rhombomere 2 development
- segment specification
- rhombomere 3 morphogenesis
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HOXA2 as an antibody target. Whether an autoantibody or antibody against HOXA2 could matter depends on whether native HOXA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HOXA2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HOXA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...